You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options. Analyzes recent developments in the natural history, immunopathology, lesion evolution, and
Filled with an abundance of reader-friendly and quick-reference tables and figures, this Fourth Edition spans the etiology, epidemiology, clinical features, diagnosis, pathology, and treatment of multiple sclerosis (MS). Surpassing other texts on the topic, this reference provides recommendations and research updates from renowned authorities in the discipline and includes chapters on recent advances in neuroimaging, molecular biology, genetics, proteinomics, disease management, and combination therapy.
None
In its 114th year, Billboard remains the world's premier weekly music publication and a diverse digital, events, brand, content and data licensing platform. Billboard publishes the most trusted charts and offers unrivaled reporting about the latest music, video, gaming, media, digital and mobile entertainment issues and trends.
Reporting on the latest advances made in treating multiple sclerosis (MS) and continuing the high standards set by earlier editions, the Handbook of Multiple Sclerosis, Third Edition examines a wide range of topics from etiology to treatment options. Analyzes recent developments in the natural history, immunopathology, lesion evolution, and therapy affecting MS treatment-including up-to-date research results from experimental therapies with t-cell vaccines, oral myelin, and monoclonal antibodies! Summarizing previous breakthroughs and pointing the way toward future research, the Handbook of Multiple Sclerosis, Third Edition provides a historical summary of the disease and examines the epidem...
For physicians using neuroactive drugs in their clinical practice, neurologists and psychiatrists most from the US and Britain, but others from India, Singapore, and Australia review movement disorders due to dopamine-blocking agents, drugs used in mood disorders, sympathomimetic drugs including lev.